FDA Inspection 1034327 — Central Maine Medical Center/BB
The FDA completed an inspection of Central Maine Medical Center/BB on Nov 7, 2017 in Lewiston, ME. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 7, 2017
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lewiston, ME (United States)